Rezolve AI Shares Surge On Microsoft Partnership Announcement: What You Need To Know
Rezolve AI Shares Surge On Microsoft Partnership Announcement: What You Need To Know
Rezolve AI Limited (NASDAQ:RZLV) shares are trading higher Thursday after the company announced a strategic partnership with Microsoft Corporation (NASDAQ:MSFT) to enhance global retail innovations using AI-powered commerce solutions.
Rezolve AI有限公司（纳斯达克：RZLV）股价周四上涨，因公司宣布与微软-t（纳斯达克：MSFT）达成战略合作伙伴关系，利用人工智能驱动的商业解决方案增强全球零售创新。
What To Know: Rezolve AI and Microsoft have formed a collaboration to provide advanced digital engagement capabilities to retailers. Rezolve AI's Brain Suite—which includes Brain Commerce, Brain Checkout, and Brain Assistant—will be hosted on Microsoft Azure and available through the Azure Marketplace.
相关信息：Rezolve AI和微软已合作提供先进的数字化参与能力给零售商。 Rezolve AI的Brain Suite——包括Brain Commerce、Brain Checkout和Brain Assistant——将托管在Microsoft Azure上，并通过Azure Marketplace提供。
The partnership includes extensive Go-to-Market (GTM) and co-sell support from Microsoft for five years. This includes marketing, sales support through Microsoft's 35,000 incentivized sellers, and technical assistance from the Microsoft AI Cloud Partner Program.
这项合作包括微软在五年内提供的广泛市场推广（GTM）和联合销售支持。其中包括通过微软的35,000名受激励销售员提供的营销、销售支持，以及来自微软人工智能云合作伙伴计划的技术支持。
What Else: Rezolve AI's Brain Suite aims to address common eCommerce challenges such as reducing cart abandonment and improving customer engagement with AI capabilities available in 95 languages. The solutions are designed to enhance operational efficiency and provide a quick return on investment (ROI).
其他信息：Rezolve AI的Brain Suite旨在解决常见的电子商务挑战，如减少购物车弃购率，并利用95种语言中可用的人工智能功能改善客户参与度。这些解决方案旨在提高运营效率并实现快速的投资回报（ROI）。
RZLV And MSFT Price Action: Rezolve shares were up by 29.7% at $8.52 and Microsoft shares were up by 0.01% at $417.09 at the time of writing, according to Benzinga pro.
RZLV和MSFT股价表现：根据Benzinga Pro，Rezolve股价在撰写时上涨了29.7%，达到8.52美元，微软股价上涨了0.01%，达到417.09美元。
- Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
- 医保药品价格谈判项目获得第二轮最终指导，预计可节省15亿美元。
Image via Unsplash.
通过Unsplash获取图片。
